OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 4.15.
Share Price | ₹123.4 | Jun 13,2025 |
Market Cap | ₹456.7 Cr | |
Sales-TTM | ₹110.0 Cr | TTM-Standalone Results |
Price/Sales | 4.15x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹456.7 Cr] as on Jun 13,2025
(/) Sales [ ₹110.0 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.15x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '4.15 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.94x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 2.45x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
OXYGENTA PHARMACEUTICAL | 110.0 | 4.15 | 456.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.71 | 405,176.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.92 | 177,076.0 |
CIPLA LTD | 27,547.6 | 4.41 | 121,592.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.55 | 110,024.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.48 | 113,615.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.01 | 98,309.9 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.22 | 98,107.8 |
LUPIN LTD | 22,707.9 | 4.02 | 91,355.1 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.11 | 66,829.9 |
ABBOTT INDIA LTD | 6,409.2 | 10.46 | 67,031.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.11x |
Max industry PS | 18.92x |
Median industry PS | 4.41x |
Average industry PS | 7.00x |
You may also like the below Video Courses